PlexusDx vs Hims & Hers
$189/mo against $238/mo for tirzepatide. Which is worth it, and for whom.
Updated 2026-09-18
DISCLOSURE — Coreage Rx pays this desk a commission when a reader signs up through our link. It buys no ranking, no score and no deletions. Method: how we rate. Full terms: disclosure.
Both sell tirzepatide. PlexusDx costs $189 a month and Hims & Hers costs $238, a difference of $49 a month or about $588 a year. The desk reads it as follows.
PlexusDx is pharmacy transparency and genetic testing. Hims & Hers is widest range of formats. They are not aimed at the same person, and the cheaper one is not automatically the right answer — though on this board it usually is.
Advert against bill. PlexusDx advertises $129 and bills $189; Hims & Hers advertises $199 and bills $238. The gaps are different sizes, which means comparing the two on their advertised prices gives you the wrong answer.
Side by side
| PlexusDx | Hims & Hers | |
|---|---|---|
| Advertised from | $129 | $199 |
| Membership on top | None | $39/mo |
| True monthly cost | $189 | $238 |
| Roughly, per year | $2,268 | $2,856 |
| Price includes medication | Yes | Yes |
| Names its pharmacy | Yes | Not published |
| Our score | 4.4 / 5 | 3.5 / 5 |
Prices verified 2026-09-18. "True monthly cost" is what you are billed in month two, once any introductory rate has lapsed and any membership has renewed.
The split
They differ on 3 of the 7 things we track, and behave the same on the other 4. The differences are what the price gap is actually buying.
| PlexusDx | Hims & Hers | |
|---|---|---|
| Price is the same at every dose | Yes | No |
| Names the compounding pharmacy publicly | Yes | No |
| Can dispense FDA-approved branded medication | No | Yes |
What each puts on the record: PlexusDx
- GLP-1 weight-loss programmes start at $129/month.
- Compounded semaglutide injection listed at $189/month with no membership fee and the same price at every dose.
- A $189/month microdose tier is offered for compounded semaglutide or tirzepatide.
- No membership or platform fee is charged alongside the medication.
- Publicly names six 503A pharmacy partners: Belmar, Strive, Epiq Scripts, Casa Pharma Rx, The Pharmacy Hub and Foothills.
- Clinical oversight via LionMD, with named physicians and NPI numbers published.
- Licensed providers in all 50 states; CLIA-certified labs for its testing line.
Where it wins: The most detailed pharmacy disclosure in this comparison — six named 503A partners. Watch for: The advertised "from $129" is the programme floor. Budget $189/month for the compounded injection tier.
What each puts on the record: Hims & Hers
- Weight-loss membership advertised at $39 for the first month.
- Compounded GLP-1 injections priced from $199/month.
- Oral medication kits priced from $79/month.
- Branded Zepbound offered at $1,899/month.
- Company has announced oral semaglutide pricing starting around $49/month, with the 1.5 mg dose around $149/month.
Where it wins: One account covers oral, compounded injectable and branded options. Watch for: The advertised entry prices and the membership are separate charges. Add $39/month to whatever medication figure you were quoted.
In each one’s favour
PlexusDx.
- The most detailed pharmacy disclosure in this comparison — six named 503A partners.
- Names its prescribing physicians along with their NPI numbers.
Hims & Hers.
- One account covers oral, compounded injectable and branded options.
- Large enough to keep supply steady when smaller sellers run dry.
How they score
| What we weigh | Weight | PlexusDx | Hims & Hers |
|---|---|---|---|
| True monthly cost | 30% | 4.6 | 3.4 |
| Price honesty | 20% | 4.5 | 3.2 |
| Clinical support | 20% | 3.8 | 3.6 |
| Pharmacy sourcing | 15% | 4.9 | 3.9 |
| Cancelling | 15% | 4 | 3.3 |
PlexusDx scores higher overall at 4.4 out of 5. The weights are published on how we rate, and so is the note about which of these is our paid featured partner.
The desk’s call
- Pick PlexusDx if cost is the binding constraint. Over a year the gap is about $588, which is real money for the same class of medication.
- Pick Hims & Hers if what it does better matters to you — one account covers oral, compounded injectable and branded options.
- If sourcing matters, note that PlexusDx publishes which pharmacy compounds its medication and Hims & Hers does not.
The verdict
On the board, PlexusDx at $189 a month is the more defensible choice on arithmetic alone. Hims & Hers earns its premium only if you will actually use what it does differently. Read the full reviews before deciding: PlexusDx and Hims & Hers.
How they sit against everyone else
| Programme | Advertised | Billed | Gap | Vs board floor |
|---|---|---|---|---|
| Coreage Rx | $149 | $199 | +$50 | +$74/mo |
| Trimi | $125 | $125 | none | — |
| Ozari Health | $125 | $125 | none | — |
| Fifty 410 | $133 | $133 | none | +$8/mo |
| PlexusDx | $129 | $189 | +$60 | +$64/mo |
| Ivím Health | $199 | $199 | none | +$74/mo |
| Zealthy | $216 | $216 | none | +$91/mo |
| Hims & Hers | $199 | $238 | +$39 | +$113/mo |
| Coby Health | $179 | $239 | +$60 | +$114/mo |
| Mochi Health | $199 | $278 | +$79 | +$153/mo |
| Eden | $199 | $298 | +$99 | +$173/mo |
| Lemonaid Health | $229 | $348 | +$119 | +$223/mo |
More from the desk
- PlexusDx tirzepatide review
Advertised at $129, billed at $189. Position 5 of 18 on our board.
- Hims & Hers tirzepatide review
Advertised at $199, billed at $238. Position 8 of 18 on our board.
- How to spot a bad seller
The FDA sent more than 55 warning letters to online GLP-1 sellers in one day. Here is how to tell a licensed programme from the rest.
- The twelve-month cost
Month one is the cheapest month you will have. Here is the full-year arithmetic, including the costs nobody puts in the advert.
- Cheapest right now
Every programme sorted on what it bills, not what it advertises. Floor: $199/mo tirzepatide, $149/mo semaglutide.
